BRIDGE LANE GROUP PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: H85045 | LONDON, SW11 3AD
Showing results 451-500 of 581
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 22 | 400 | £572 | +127.7% ▲ | |
| Zuclopenthixol decanoate | 21 | 87 | £485 | +30.8% ▲ |
| Specialist food replacer rolls/baguettes (0913261) | 21 | 32.8K | £550 | +221.7% ▲ |
| Fluorometholone | 21 | 285 | £89 | +45.8% ▲ |
| 21 | 598 | £419 | -43.4% ▼ | |
| Terbutaline sulphate | 20 | 32 | £253 | -63.1% ▼ |
| Clindamycin hydrochloride | 20 | 850 | £207 | +99.8% ▲ |
| Vitamins caps | 20 | 656 | £13 | -63.6% ▼ |
| Lidocaine | 20 | 540 | £513 | +74.0% ▲ |
| 20 | 2,125 | £38 | -20.5% ▼ | |
| 20 | 340 | £938 | -58.2% ▼ | |
| Ipratropium bromide | 19 | 1,057 | £322 | -33.9% ▼ |
| Paliperidone | 19 | 25 | £7.9K | +25.0% ▲ |
| Bupropion hydrochloride | 19 | 1,740 | £1.2K | +75.8% ▲ |
| Pivmecillinam hydrochloride | 19 | 232 | £123 | -63.8% ▼ |
| 19 | 330 | £723 | -41.7% ▼ | |
| 19 | 1,320 | £2.0K | +3.2% ▲ | |
| Oral rehydration salts | 18 | 256 | £104 | -37.7% ▼ |
| Ketotifen fumarate | 18 | 830 | £208 | +93.5% ▲ |
| Acetic acid | 18 | 135 | £126 | +55.4% ▲ |
| 18 | 900 | £3.0K | +52.9% ▲ | |
| Enoxaparin | 17 | 443 | £2.8K | -17.1% ▼ |
| Modafinil | 17 | 762 | £52 | -18.5% ▼ |
| Tibolone | 17 | 1,386 | £126 | -44.5% ▼ |
| Testosterone undecanoate | 17 | 17 | £1.5K | -33.0% ▼ |
| Powder 10g protein equivalent (0913226) | 17 | 1,548 | £9.3K | +47.1% ▲ |
| Midazolam hydrochloride | 17 | 170 | £107 | -58.5% ▼ |
| 17 | 1,020 | £3.2K | +33.1% ▲ | |
| 17 | 1,110 | £5.5K | +46.4% ▲ | |
| 17 | 600 | £3.0K | -62.4% ▼ | |
| 17 | 1,004 | £251 | -42.1% ▼ | |
| Sodium citrate (Rectal) | 16 | 148 | £97 | +16.0% ▲ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 16 | 788 | £132 | -54.0% ▼ |
| Hydroxyzine hydrochloride | 16 | 1,386 | £44 | -70.0% ▼ |
| Valproic acid | 16 | 960 | £173 | -81.6% ▼ |
| Exemestane | 16 | 1,236 | £287 | -50.8% ▼ |
| Amorolfine hydrochloride | 16 | 80 | £93 | -30.7% ▼ |
| 16 | 410 | £869 | -24.3% ▼ | |
| 16 | 1,020 | £1.7K | -67.2% ▼ | |
| 16 | 1,320 | £2.5K | -52.6% ▼ | |
| 16 | 340 | £84 | +8.7% ▲ | |
| 16 | 160 | £600 | -14.3% ▼ | |
| Sodium picosulfate | 15 | 4,500 | £401 | -58.7% ▼ |
| Dabigatran etexilate | 15 | 2,328 | £1.8K | -71.0% ▼ |
| Aripiprazole | 15 | 15 | £3.3K | -1.5% vs avg |
| Hyoscine | 15 | 249 | £1.6K | +116.1% ▲ |
| Pizotifen malate | 15 | 1,216 | £55 | -81.8% ▼ |
| Zonisamide | 15 | 1,904 | £829 | -65.6% ▼ |
| Mebendazole | 15 | 252 | £20 | +31.0% ▲ |
| Betamethasone sodium phosphate | 15 | 630 | £83 | +22.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.